Review: Genetics of systemic lupus erythematosus

Arnetti FC , Reveille JD Genetics of systemic lupus erythematosus. Rheum Dis Clin N Am 1992; 18: 865-892.

Arnett FC The genetic basis of lupus erythematosus. In: Wallace DJ , Hahn BH (eds) Dubois Lupus Erythematosus 4th edn. Philadelphia. Lea & Febiger, 1992.

Block SR et al. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 1975; 59: 533-552.

Kaplan D. The onset of disease in twins and siblings with systemic lupus erythematosus . J Rheumatol 1984; 11: 648-652.

Deapen D. et al. A revised estimate of twin concordance in systemic lupus erythematosus . Arthritis Rheum 1992; 35: 311-318.

Jarvinen P. et al. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med 1992; 231: 67-72.

Buckman KJ et al. Familial systemic lupus erythematosus. Arch Intern Med 1978; 138: 1674-1676.

Lawrence JS , Martins CL , Drake GL A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987; 14: 913-921.

Hochberg M. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987; 14: 867-869.

Slor H. et al. The genetics of autoimmunity: the familial tendency of systemic lupus erythematosus. Isr J Med Sci 1989; 25: 678-682.

Aggarwal A. et al. Occurrence of systemic autoimmune disorders and autoantibodies in household contacts of patients with systemic lupus erythematosus . Indian J Med Res 1991; 94: 96-98.

Chantler S. et al. Incidence of nuclear antibodies in patients and in related and unrelated groups from a community with a 'micro-epidemic' of systemic lupus erythematosus. Clin Immunol Immunopath 1973; 2: 9-15.

Isenberg DA et al. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum 1985; 28: 99-1007.

Halpern R. et al. Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members. J Clin Invest 1985; 76: 731-736.

Silvestris F. et al. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus. Clin Exp Immunol 1985; 60: 329-338.

Spencer-Green G. et al. Familial alterations of immunoregulation in systemic lupus erythematosus. J Rheumatol 1985; 12: 498-503.

Dudeney C. et al A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members . Ann Rheum Dis 1986; 45: 502-507.

Segal R. et al. Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1986; 66: 52-60.

Schattner A. et al. Supressor cell function and anti-DNA antibody idiotypes in the serum of SLE patients and their first-degee relatives . Clin Immunol Immunopathol 1986; 41: 417-426.

Shoenfeld Y. et al. Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum 1987 ; 30: 169-175.

Mackworth-Young C. et al. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 723-726.

Dang H. et al. Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives. Clin Exp Immunol 1988; 71: 445-450.

LePage SH et al Relationship between tymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses. Clin Exp Immunol 1989; 77: 314-318.

Silvestris F. et al. Studies of anti-F(ab')2 antibodies and VH region distribution among SLE kindreds. J Autoimmun 1989; 2: 395-401.

Silvestris F. et al. Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds . J Clin Immunol 1989; 9: 462-468.

Arnett FC et al. Genetic studies of Ro(SS-A) and La(SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1989; 32: 413-419.

Mendlovic S. et al. Anti-DNA idiotype and anti-idiiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives. Clin Exp Immunol 1990; 82: 504-508.

Vasan RS et al. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus and their household contacts. Indian J Med Res 1990; 92: 447-450.

Sato EI et al. Systemic lupus erythematosus: a family study of 25 probands . Clin Exp Rheumatol 1991; 9: 455-461.

Strom BL et al. Shingles, allergies, family medical history, oral contraceptives and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994; 140: 632-642.

Haug BL , Lee JS , Sibley JT Altered poly(ADP-ribose) metabolism in family members of patients with systemic lupus erythematosus. J Rheumatol 1994; 21: 851-856.

A. Scherak 0, Smolen JS, Mayr WR. HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 1980; 23: 954-957.

Winchester RJ Genetic aspects. In: Schur PH (ed.). Clinical Management of Systemic Lupus Erythematosus . Grune & Stratton: New York , 1983, pp 17-27.

Whittingham S. et al. HLA and Gm genes in systemic lupus erythematosus. Tissue Antigens 1983; 21: 50-57.

Whittingham S. , Propert DN , Mackay IR A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype km(1). Immunogenetics 1984; 19: 295-299.

Dunckley H. , Gatenby PA , Serjeantson SW DNA typing of HLA-DR antigens in systemic lupus erythematosus. Immunogenetics 1986; 24: 158-162.

Dunckley H. et al. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987: 14: 209-218.

Christiansen FT et al. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus. C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol 1991; 18: 1350-1358.

Fernandes Srm et al. HLA antigens and susceptibility to systemic lupus erythematosus in Brazilian patients. Lupus 1995; 4: 43S.

Benovolenskaia LI , Iakovleva DB , Folomeeva OM The importance of HLA antigens for the prognosis of the course and effect of treatment in systemic lupus erythematosus. Vutr. Boles 1988; 27: 48-52.

Bell DA et al. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset and sex. J Rheumatol 1984; 11: 475-479.

Goldstein R. , Smith CD , Sengar Dps. MHC class II studies of primary antiphospholipid antibody (aPLA) syndrome and of serum antiphospholipid antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum 1990; 33: S125 (abstract).

Goldstein R. , Sengar Dps. Comparative studies of HLA associations and C4A gene deletion in French Canadian and non-French Canadian Caucasians with SLE. Presented at the 15th Annual Meeting of the American Society of Histocompatibility and Immunogenetics, 12-21 September 1989, Toronto .

Goldstein R. , Sengar DP Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1121-1127.

Stenszky V. et al. Heterogeneity of systemic lupus erythematosus elucidated by cluster analysis. The influence of HLA. J Immunogen 1986; 13: 327-340.

Gladman DD et al. Increased frequency of HLA-DRw2 in SLE. Lancet 1972; 2: 902-905.

Hawkins BR et al. Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. J Rheumatol 1987; 14: 1128-1131.

Doherty DG et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum 1992; 35: 641-646.

Joung-Liang L. , Jen-Pey Su P. , Wen-Yin T. Complement C4 allotyping in patients with systemic lupus erythematosus in Chinese. J Rheum (ROC) 1987; 4: 23-29.

Dostal C. et al. HLA antigens in SLE. Ann Rheum Dis 1977; 36: 83-85.

Cowland JB et al. DNA polymorphism of HLA class II genes in systemic lupus erythematosus . Tissue Antigens 1994; 43: 34-37.

Fugger L. et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 1989; 34: 17-22.

Green JR , Montasser M. , Woodrow JC The association of HLA-linked genes with systemic lupus erythematosus. Ann Hum Genet 1986; 50: 93-96.

Batchelor JR et al. Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70: 364-371.

So AK et al. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus. Tissue Antigens 1990; 35: 144-147.

Briggs DC et al. Influence of C4 null alleles on C4 activation in systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 251-254.

Galeazzi M. et al. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol 1992; 19: 42-46.

Davies EJ et al. HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus . Br J Rheumatol 1993; 32: 870-875.

Davies EJ et al. HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 188-190.

Davies EJ et al. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 61-63.

Wilson AG et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191-195.

Partanen J. , Koskimies S. , Johansson E. C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes. J Med Genet 1988; 25: 387-391.

Ruuska P. et al. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 52-55.

Stoppa-Lyonnet D. et al. Familial studies of systemic lupus erythematosus. HLA markers and complotypes. Pathol Biol 1986; 34: 773-777.

Gougerot A. et al. HLA markers and complotypes: risk factors in systemic lupus erythematosus? Ann Dermatol Venereol 1987; 114: 329-334.

Clemenceau S. et al. C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease ? Pediatr Nephrol 1990; 4: 207-212.

Fan Q. et al. Complement component C4 deficiencies and gene alterations in patients with systemic lupus erythematosus. Eur J Immunogen 1993; 20: 11-21.

Monplaisir N. et al. Study of HLA antigens in systemic lupus erythematosus in the French West Indies. Tissue Antigens 1988; 31: 238-242.

Hartung K. et al. Association of class I, II and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int 1989; 9: 13-18.

Hartung K. et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992; 90: 1346-1351.

Bettinotti MP et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993; 37: 449-454.

Yao Z. et al. No direct correlation between HLA-DPB 1 and antibodies against recombinant Ro(SS-A)/La (SS-B) proteins in systemic lupus erythematosus. Rheumatol Int 1993; 13: 155-158.

Yao Z. et al. DNA typing for HLA-DPB 1-alleles in German patients with systemic lupus lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group. Eur J Immunogen 1993; 20: 259-266.

Yao Z. et al. Polymorphism of the DQA 1 promoter region (QAP) and DRB 1, QAP, DQA1, DQB 1 haplotypes in systemic lupus erythematosus. SLE Study Group members . Immunogenetics 1993; 38: 421-449.

Reveille JA et al. HLA class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. Tissues Antigens 1995 (in press).

Stenszky V. et al. Interplay if immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis. J Immunogenet 1986; 13: 11-17.

Mehra NK et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in northern India. Lupus 1993; 2: 313-314.

Savi M. et al. HLA-DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-1570.

Lulli P. et al. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens. Clin Exp Rheumatol 1991; 9: 475-479.

Galeazzi M. et al. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol 1992; 19: 42-46.

Kameda S. et al. HLA antigens of patients with systemic lupus erythematosus. Tissue Antigens 1981; 20: 221-222.

Hashimoto H. et al. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985; 12: 919-923.

Nishikai M. , Sekiguchi S. Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases. Arthritis Rheum 1985; 28: 579-581.

Hirose S. et al. Association of HLA-DR2/DR4 heterozygosity with systemic lupus erythematosus in Japanese patients. J Rheumatol 1988; 15: 1489-1492.

Yamada H. et al. Lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1054-1057.

Dong RP et al. Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 1993; 41: 20-25.

Hashimoto H. et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994; 23: 191-196.

Nishimura Y. HLA-linked susceptibility to intractable vasculitis syndrome. Nippon Rinsho 1994; 52: 2000-2005.

Hong GH et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J Rheumatol 1994; 21: 442-447.

Fouad F. et al. MHC in systemic lupus erythematosus: a study on a Kuwaiti population . Eur J Immunogenet 1994; 21: 11-14.

Granados J. et al. Further evidence of the role of complement genotypes in the susceptibility to SLE obtained from Mexican family studies . Arthritis Rheum 1987; 30: S21 (abstract).

Kumar A. , Kumar P. , Schur PH DR3 and non-DR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60: 55-64.

Benevolenskaia LI et al. The HLA system and its contribution to the genetics of rheumatic diseases. Genetika 1986; 22: 861-867.

Alexeev LP , Petrov RV Unusual association of HLA antigens to systemic lupus erythematosus (SLE) predisposition. Lupus 1995; 4: 42S.

Skarsuag S. et al. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non [DRB 1 *03, DQA 1 *0501, DQB1*0201] class II homozygotes? Tissue Antigens 1992; 40: 128-133.

Howe HS et al. HLA DR antigens in Singapore Malay SLE patients. Lupus 1995; 4: 22S.

Bosak V. et al. Genetic analysis in SLE-Slovak population study. Lupus 1995; 4: 43S.

Klemp P. et al. HLA-A,B,C, and DR antigens, GLO I and Bf marker profiles in 75 Cape coloured patients with systemic lupus erythematosus (SLE). Tissue Antigens 1988; 32: 12-16.

De Juan D. et al. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum Genet 1993; 91: 579-584.

Camps Garcia MT et al. Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain. Med Clin (Barc) 1994; 102: 688-693.

Rantapaa DS , Beckman G. , Beckman L. Serum protein markers in systemic lupus erythematosus . Hum Hered 1988; 38: 44-47.

Sturfelt G. et al. Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet 1990; 38: 427-433.

Truedsson L. , Sturfelt G. , Nived O. Prevalence of the type I complement C2 deficiency gene in Swedish systemic lupus erythematosus patients. Lupus 1993; 2: 325-327.

Reinharz D. et al. Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus. Tissue Antigens 1991; 37: 10-15.

Fraser PA et al. Complotypes of individuals of African origin: frequencies and possible extended MHC haplotypes. Immunogenetics 1990; 31: 89-93.

Reveille JD et al. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. J Rheumatol 1991; 18: 14-18.

Reveille JD et al. DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1243-1251.

Alvarellos A. et al. Relationships of HLA-DR and MT antigens to autoantibody expression in SLE. Arthritis Rheum 1983; 26: 1533-1535.

Hochberg MC et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285-295.

Howard PF et al. Relationship between C4 null genes, HLA-D region antigens and genetic susceptibility to systemic lupus erythematosus in caucasian and black Americans. Am J Med 1986; 81: 187-193.

Petri M. et al. Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine 1993; 72: 236-244.

Glass D. et al. Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 1976; 58: 853-861.

Schur PH et al. The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1990; 33: 985-992.

Kachru RN et al. A significant increase of HLA-DR3 and DR2 in systemic lupus erythematosus among Blacks. J Rheumatol 1984 ; 11: 471-474.

Welch TR et al. Major histocompatibility complex extended haplotypes in systemic lupus erythematosus. Dis Markers 1988; 6: 247-255.

Bishof NA et al. DP polymorphism in HLA-A1, -B8, -DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus . Pediatr Nephrol 1993; 7: 243-246.

Arnett FC et al. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J Rheumatol 1990; 17: 1029-1035.

Wilson WA , Scopelitis E. , Michalski JP Association of HLA-DR7 with both antibody to SSA(Ro) and disease susceptibility in Blacks with systemic lupus erythematosus. J Rheumatol 1984; 11: 653-657.

Kemp ME et al. Deletion of C4A genes in patients with systemic lupus erythematosus . Arthritis Rheum 1987; 30: 1015-1022.

Fronek Z. et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1980; 33: 1542-1553.

Fronek Z. et al. Major histocompatibility complex associations with systemic lupus erythematosus. Am J Med 1988; 85: 42-44.

Olsen ML et al. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics 1989; 30: 27-33.

Barron KS et al. Clinical serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993; 36: 348-354.

Reveille JD et al. HLA-DPB 1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance. Tissue Antigens 1992 ; 40: 45-48.

Reveille JD et al. HLA-DR, DQ and DP genotypes in Mexican-Americans with systemic lupus erythematosus the importance of autoantibody subsets in HLA/disease associations. Arthritis Rheum 1991 ; 34: S138.

Reveille JD et al. The molecular genetics of systemic lupus erythematosus (SLE) in Mexican-Americans. Arthritis Rheum 1991; 34: S138 (abstract).

Reveille JD , Moulds JM , Arnett FC Major histocompatibility complex class II and C4 alleles in Mexican-Americans with systemic lupus erythematosus. Tissue Antigens 1995; 45: 91-97.

Alarif LI , Ruppert GB , Wilson R.Jr , Barth WF HLA-DR antigens in blacks with rheumatoid arthritis and systemic lupus erythematosus . J Rheumatol 1983; 10: 297-300.

Schur PH et al. Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. Clin lmmunol Immunopathol 1982; 24: 263-275.

Griffing WL et al. Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J Exp Med 1980; 152: 319s-325s.

Khanduja S. , Arnett FC , Reveille JD HLA-DQ beta genes encode an epitope for lupus specific DNA antibodies. Clin Res 1991; 38: 975A (abstract).

Nishikai M. , Sekiguchi S. Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases. Arthritis Rheum 1985; 28: 579-581.

Smnolen JS et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens . Annal Rheum Dis 1987; 46: 457-462.

Olsen ML , Arnett FC , Reveille JD Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus . Arthritis Rheum 1993; 36: 94-104.

Stephens HA et al. HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus. Immunogenetics 1991; 33: 276-280.

Kaneoka H. et al. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70 kd autoantibody positive connective tissue disease patients. Arthritis Rheum 1992; 35: 83-94.

Gomez-Reino JJ et al. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers. Immunobiology 1991; 182: 465-471.

Bell DA , Maddison PJ Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980; 23: 1268-1272.

Wong KL , Hawkins BR , Wong RW Immunogenetics in Chinese patients with SLE. Scand J Rheumatol 1991; 20: 110-114.

Stephens HA et al. HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus. Immunogenetics 1991; 33: 276-280.

Specker C. et al. Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers. Dtsch Med Wochenschr 1987; 112: 577-580.

Hartung K. et al. The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study . Rheumatol Int 1992; 11: 243-249.

Ehrfeld H. et al. MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Rheumatol Int 1992; 12: 169-173.

Provost TT , Arnett FC , Reichlin M. Homozygous C2 deficiency, lupus erythematosus and anti-Ro (SSA) antibodies. Arthritis Rheum 1983; 26: 1279-1282.

Hamilton RG et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496-505.

Scofield RH et al. Cooperative association of T cell beta receptor and HLA-DQ alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopath 1994 ; 72: 335-341.

Scofield RH et al. Immunogenetics of epitopes of the carboxyl terminus of the human 60-kD Ro autoantigen. Clin Exp Immunol 1995; 99: 256-261.

Fujisaku A. et al. HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 1990; 86: 606-611.

Reveille JD et al. Specific amino acid residues in the second hypervariable region of HLA-DQA 1 and DQB 1 chain genes promote the Ro(SS-A)/La (SS-B) autoantibody responses. J Immunol 1991 ; 146: 3871-3876.

Camps MT et al. Immunogenetics characteristics of lupus patients with secondary antiphospholipid syndrome. Lupus 1995; 4: 22S.

Arnett FC et al. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991 ; 87: 1490-1495.

Reveille JD et al. HLA-DPB alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance. Tissue Antigens 1992; 40: 45-48.

McHugh NJ , Maddison PJ HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1623-1624.

Hartung K. et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study . SLE Study Group. Autoitnmunity 1992; 13: 95-99.

Gulko PS et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations and impact on survival. J Rheumatol 1993; 20: 1684-1693.

Wilson WA et al. Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15: 1768-1772.

Kumana CR et al. Lack of association between slow acetylator status and spontaneous lupus erythematosus. Clin Pharmacol Ther 1990 ; 48: 208-213.

Ong ML et al. The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese. Br J Rheumatol 1990; 29: 462-464.

Reidenberg MM et al. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 1993; 36: 971-973.

Uko G. et al. CR1 deficiency in SLE: acquired or genetic? Clin Exp Immunol 1985; 62: 329-336.

Moldenhauer F. , Botto M. , Walport MJ The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin Exp Immunol 1988; 72: 74-78.

Moldenhauer F. et al. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum 1987; 30: 961-966.

Holme E. et al. Decreased C3b receptors (CR 1 ) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986; 63: 41-48.

Walport MJ et al. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59: 547-554.

Cornellet P. et al. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin Exp Immunol 1992; 89: 22-25.

Mir A. et al. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study. Clin Exp Immunol 1988; 73: 461-466.

Cohen JH et al. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 393-397.

Satoh H. et al. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1. Ann Rheum Dis 1991; 50: 765-768.

Miyakawa Y. et al. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981; 2: 493-497.

Tebib JG et al. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1465-1469.

Wilson JG et al. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR 1 gene. J Immunol 1987; 138: 2708-2710.

Iida K. , Mornaghi R. , Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 1982; 155: 1427-1438.

Van Dyne S. et al. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus . Clin Exp Immunol 1987; 68: 570-579.

Whittingham S. , Propert DN , Mackay IR A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1). Immunogenetics 1984; 19: 295-299.

Jazwinska EC et al. Gm allogenotype distribution and lack of HLA-DR, Gm interaction in SLE and CREST/PSS. Immunol Cell Biol 1989; 67: 261-265.

Strejcek J. , Herzog P. , Bielicky T. Allotypy of serum immunoglobulins in systemic and chronic lupus erythematosus. Int Arch Allergy 1967; 31: 145-151.

Hartung K. et al. Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group. Rheumatol Int 1991; 11: 179-182.

Hauke G. et al. Immunoglobulin and T cell receptor gene rearrangements in patients with autoimmune diseases. Immun Infekt 1990 ; 18: 96-97.

Hartung K. et al. Immunoglobulin allotypes in systemic lupus erythematosus: results of a central European multicenter study. SLE Study Group. Exp Clin Immunogenet 1991; 8: 11-15.

Schur PH , Pandey JP , Fedrick JA Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 828-830.

Fedrick JA et al. Gm allotypes in blacks with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 828-830.

Hoffman RW et al. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum 1991; 34: 453-458.

Singh R. , Mullinax PF , Moxley G. Systemic lupus erythematosus is not associated with allotypic markers of immunoglobulin kappa in Caucasians. J Rheumatol 1994; 21: 839-842.

Dunckley H. , Gatenby PA , Serjeantson SW T cell receptor and HLA class II RFLPs in systemic lupus erythematosus. Immunogenetics 1988; 27: 392-395.

Ikaheimo IL et al. Different distribution of T cell receptor beta-chain haplotypes in mixed connective tissue disease and systemic lupus erythematosus. Ann Med 1994; 26: 129-132.

Morito F. et al. Genetic analysis of systemic lupus erythematosus: association with a T cell receptor restriction fragment length polymorphism in Japanese patients. Intern Med 1992; 31: 998-1003.

Tebib JG et al. Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990; 86: 1961-1967.

Wong DW et al. Non-linkage of the T cell receptor alpha, beta and gamma genes to systemic lupus erythematosus in multiplex families. Arthritis Rheum 1988; 31: 1371-1376.

Fronek Z. et al. Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor. Arthritis Rheum 1986; 29: 1023-1025.

Graninger WB Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic lupus erythematosus. Wien Klin Wochenschr 1992; 104: 205-207.

Jiang Z. , Du C. Studies of the relationship between transferrin genetic polymorphism and diseases . I Chuan Hseuh Pao 1992; 19: 298-202.

Chan SH et al. HLA and systemic lupus erythematosus in Chinese. Hum Immunol 1981; 3: 345-350.

Fugger L. et al. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J Immunogenet 1989; 16: 461-465.

Davies EJ et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 110-114.

Blakemore AI et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1380-1385.

Wysenbeek AJ et al. Expression of systemic lupus erythematosus in various ethnic Jewish Israeli groups. Ann Rheum Dis 1993; 52: 268-271.

Atsumi T. Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells. Hokkaido Igaku Zasshi 1992 ; 67: 408-419.

Kawai T. et al. HLA antigens in Japanese patients with central nervous system lupus. Tissue Antigens 1990; 35: 45-46.

Teh LS , Doherty DG , Williams BD HLA-DRB genes and antiribosomal P antibodies in systemic lupus erythematosus . Br J Rheumatol 1994; 33: 1125-1126.

Kumar A. et al. Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1991 ; 34: 1553-1556.

Glavinskaia TA et al. HLA and ceruloplasmin phenotypes in lupus erythematosus and circumscribed scleroderma. Vestn Dermatol Venerol 1989; 6: 9-13.

Welch TR , Berry A. C3 alleles in diseases associated with C3 activation. Dis Markers 1987; 5: 81-87.

Jazwinska EC et al. Fc gamma RII restriction fragment length polymorphism (RFLP): analysis in systemic lupus erythematosus and scleroderma and evidence of an alpha gene duplication. Clin Exp Immuuol 1991; 83: 47-51.

Harley JB et al. Systemic lupus erythematosus: considerations for a genetic approach . J Invest Dermatol 1994; 103: 144S-149S.

Freedman BI et al. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. Am J Kidney Dis 1993; 21: 378-382.

Watson RM et al. Subacute cutaneous lupus erythematosus-immunogenetic associations . J Autoimmun 1991; 4: 73-85.

Schur PH Fingerprint analysis of patients with systemic lupus erythematosus and their relatives. J Rheumatol 1990; 17: 482-484.

Jacob CO et al. Heritable major histocompatibility complex class IIassociated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.

Dubois RW , Weiner JM , Dubois EL Dermatoglyphic study of systemic lupus erythematosus. Arthritis Rheum 1976; 19: 87-97.

Gammon WR , Briggman RA Bullous Sle. A phenotypically distinctive but immunologically heterogeneous bullous disorder . J Invest Dermatol 1993; 100: 28S-34S.

Frank MB et al. Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990; 85: 33-39.

Shoenfeld Y. et al. Diversity and pattern of inheritance of autoantibodies in families with multiple cases of systemic lupus erythematosus . Ann Rheum Dis 1992; 51: 611-618.

Teh LS et al. Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 1993; 32: 663-665.

Citera G. , Wilson WA Ethnic and geographic perspectives in SLE. Lupus 1993; 2: 351-353.

Schur PH , Carpenter CB Sharing of HLA haplotype by parents of patients with systemic lupus erythematosus . Arthritis Rheum 1983; 26: 1104-1110.

Hartung K. et al. Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE- Studie. Tissue Antigens 1991; 38: 165-168.

Schur PH Inherited complement component abnormalities. Ann Rev Med 1986; 37: 333-346.

Walport MJ Complement deficiency in SLE. Lupus 1995; 4: 8 (abstract).

Kono DH et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994; 91: 10168-10172.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1272-1277.

Hart HH , Grigor RR , Caughey DE Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 529-532.

Johnson AE et al. Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus 1994; 3: 501-506.

A Meyer O. A critical appraisal of the classification criteria for systemic lupus erythematosus . Clin Exp R heum 1994; 12 (suppl.): S41-S44.

Lander ES Schork NJ Genetic dissection of complex traits. Science 1994; 265: 2037-2048.

James JA et al. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spiceosome autoimmunity. J Exp Med 1995; 181: 453-461.

Elson CJ et al. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995 ; 16: 71-76.

Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994 ; 8: 1296-1301.

Reichlin M. Autoantibodies to the RoRNP particles. Clin Exp Immunol 1995; 99: 7-9.

Russell GI et al. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med 1987; 65: 845-852.

Mountz JD et al. Autoimmune disease. A problem of defective apoptosis. Arth Rheum 1994; 37: 1415-1420.

Theofiliopoulos AH The basis of autoimmunity. 1. Mechanisms of aberrant self-recognition. Immunol Today 1995 ; 16: 90-98.

Theofilopoulos AN The basis of autoimmunity. 2. Genetic predisposition . Immunol Today 1995; 18: 150-158.

Kammer GM , Khan IU , Malemud CJ Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 1994; 94: 422-430.

Wicks I. , McColl G. , Harrison L. New perspectives on rheumatoid arthritis. Immunol Today 1994; 15: 553-556.

Bach JF Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopath 1994; 72: 156-161.

Alper CA et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321: 708-712.

Thursz MR et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069.

Lepage V. et al. HLA-Cw7 and HBsAg negative chronic active hepatitis. Tissue Antigens 1991; 18: 105-107.

Apple RJ et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994; 6: 157-162.

Ayoub EM et al. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019-2026.

Kalish RA , Leong JM , Steere AC Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61: 2774-2779.

Potts WK , Wakeland EK Evolution of MHC genetic diversity: a tale of incest, pestilence and sexual preference. Trends Genet 1993; 9: 408-412.

Weyand CM et al. The influence of HLA-DRB 1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801-806.

Behar SM , Porcelli SA Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum 1995 ; 38: 458-476.

Penny MA et al. An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. Hum Immunol 1993; 38: 179-183.